Pharmacokinetics of parenteral and oral sustained-release morphine sulphate in dogs.

作者: S. DOHOO , R. A. R. TASKER , A. DONALD

DOI: 10.1111/J.1365-2885.1994.TB00273.X

关键词: BioavailabilityMorphineAnesthesiaVolume of distributionRadioimmunoassayDosePharmacologyPharmacokineticsAbsorption (skin)MedicineCmax

摘要: The pharmacokinetics of single-dose morphine sulphate (MS) administered intravenously (i.v.) and intramuscularly (i.m.) oral sustained-release (OSRMS) were studied in dogs. Beagles (n = 6) randomly assigned to six treatment groups using a Latin square design. Treatments included MS 0.5 0.8 mg/kg i.v. i.m. OSRMS 15 30 mg orally (p.o). Serum samples drawn at intervals up 420 min following parenteral 720 OSRMS. was analysed for concentration radioimmunoassay. Pharmacokinetic analysis the results revealed that eliminated by first-order process best described two-compartment model. For data there no statistically significant differences (P < 0.05) between steady-state volume distribution, half-life elimination plasma clearance. As expected, area under vs. time curve (AUC) significantly greater dosage routes, maximum serum longer administration. any parameter (AUC, Cmax, tmax, t1/2, F) prolonged absorption drug occurred over approximately 6 h. Bioavailability (F) both dosages 20%. route is an effective method rapid complete delivery may be useful provision long-term analgesic therapy dogs, but further work required verify safety effectiveness this preparation.

参考文章(23)
K Iwamoto, C D Klaassen, First-pass effect of morphine in rats. Journal of Pharmacology and Experimental Therapeutics. ,vol. 200, pp. 236- 244 ,(1977)
C T Walsh, R R Levine, Studies of the enterohepatic circulation of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics. ,vol. 195, pp. 303- 310 ,(1975)
ST Leslie, A. Rhodes, FM Black, Controlled release morphine sulphate tablets--a study in normal volunteers. British Journal of Clinical Pharmacology. ,vol. 9, pp. 531- 534 ,(1980) , 10.1111/J.1365-2125.1980.TB05858.X
M. VATER, G. SMITH, G.W. AHERNE, A.R. AITKENHEAD, PHARMACOKINETICS AND ANALGESIC EFFECT OF SLOW-RELEASE ORAL MORPHINE SULPHATE IN VOLUNTEERS BJA: British Journal of Anaesthesia. ,vol. 56, pp. 821- 827 ,(1984) , 10.1093/BJA/56.8.821
A. D. Finck, B. A. Berkowitz, J. Hempstead, S. H. Ngai, Pharmacokinetics of morphine: effects of hypercarbia on serum and brain morphine concentrations in the dog. Anesthesiology. ,vol. 47, pp. 407- 410 ,(1977) , 10.1097/00000542-197711000-00003
J Sawe, L Kager, JO Svensson Eng, A Rane, Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. British Journal of Clinical Pharmacology. ,vol. 19, pp. 495- 501 ,(1985) , 10.1111/J.1365-2125.1985.TB02675.X
Palle B. Neumann, Hans Henriksen, Nina Grosman, Christian Broen Christensen, Plasma morphine concentrations during chronic oral administration in patients with cancer pain Pain. ,vol. 13, pp. 247- 252 ,(1982) , 10.1016/0304-3959(82)90014-8
G.W. Hanks, G.W. Aherne, P.J. Hoskin, P. Turner, P. Poulain, EXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE? The Lancet. ,vol. 330, pp. 723- 725 ,(1987) , 10.1016/S0140-6736(87)91083-X
C. C. Hug, M. R. Murphy, E. P. Rigel, W. A. Olson, Pharmacokinetics of Morphine Injected Intravenously into the Anesthetized Dog Anesthesiology. ,vol. 54, pp. 38- 47 ,(1981) , 10.1097/00000542-198101000-00008